A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Genetic Protein May Be Key to Hindering Ability of SARS-CoV-2 to Replicate


New research shows that targeting the RNA protein, METTL3—used by the novel coronavirus to replicate—may enable the development of medications that can effectively treat COVID-19. Published in Genes and Development, the study found that the chemically inhibition of METTL3 had antiviral effects not only on SARS-CoV-2, but also on the viruses that cause the common cold. Study authors suggest this discovery bodes well for creating drugs that may stop the reproduction of the novel coronavirus. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy